104 related articles for article (PubMed ID: 29071729)
1. Melanoma or pseudo-melanoma? Change in a pigmented lesion after application of topical 5-Fluorouracil.
Haeusler KA; Hall JR; Seykora CM; Abuzeid MJ; Dalton SR
J Cutan Pathol; 2018 Jan; 45(1):97-98. PubMed ID: 29071729
[No Abstract] [Full Text] [Related]
2. A role for topical 5-fluorouracil therapy in melanoma.
Ryan RF; Krementz ET; Litwin MS
J Surg Oncol; 1988 Aug; 38(4):250-6. PubMed ID: 3045424
[TBL] [Abstract][Full Text] [Related]
3. Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracil.
Bondi EE; Clark WH; Elder D; Guerry D; Greene MH
Arch Dermatol; 1981 Feb; 117(2):89-92. PubMed ID: 7469446
[TBL] [Abstract][Full Text] [Related]
4. [Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil].
Florin V; Vercambre-Darras S; Piette F; Mortier L
Ann Dermatol Venereol; 2008; 135(8-9):603-4. PubMed ID: 18789300
[No Abstract] [Full Text] [Related]
5. Topical chemotherapy with 5-fluorouracil. A review.
Goette DK
J Am Acad Dermatol; 1981 Jun; 4(6):633-49. PubMed ID: 7016939
[No Abstract] [Full Text] [Related]
6. Melanocytic lesion evolution patterns with targeted therapies and immunotherapies for advanced metastatic melanoma: An observational study.
Zhao CY; Hwang SJE; Wakade D; Carlos G; Anforth R; Fernández-Peñas P
Australas J Dermatol; 2017 Nov; 58(4):292-298. PubMed ID: 28707403
[TBL] [Abstract][Full Text] [Related]
7. Total body topical 5-fluorouracil for extensive non-melanoma skin cancer.
van Ruth S; Jansman FG; Sanders CJ
Pharm World Sci; 2006 Jun; 28(3):159-62. PubMed ID: 17004017
[TBL] [Abstract][Full Text] [Related]
8. Vitiligo in 2 patients receiving vemurafenib for metastatic melanoma.
Alonso-Castro L; Ríos-Buceta L; Vano-Galvan S; Moreno C; Soria-Rivas A; Jaén P
J Am Acad Dermatol; 2013 Jul; 69(1):e28-9. PubMed ID: 23768302
[No Abstract] [Full Text] [Related]
9. [Melanoma and non-melanoma skin cancers].
Saito T
Gan To Kagaku Ryoho; 2008 Apr; 35(4):583. PubMed ID: 18467999
[No Abstract] [Full Text] [Related]
10. A histopathological study of melanocytic and pigmented skin lesions in patients with albinism.
van der Westhuizen G; Beukes CA; Green B; Sinclair W; Goedhals J
J Cutan Pathol; 2015 Nov; 42(11):840-6. PubMed ID: 26268889
[TBL] [Abstract][Full Text] [Related]
11. Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.
Miller AK; Dusing R; Meggison A; Aires D
J Drugs Dermatol; 2011 Mar; 10(3):302-5. PubMed ID: 21369648
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: patterns of modifications observed in early melanoma, atypical nevi, and common nevi.
Kittler H; Pehamberger H; Wolff K; Binder M
J Am Acad Dermatol; 2000 Sep; 43(3):467-76. PubMed ID: 10954658
[TBL] [Abstract][Full Text] [Related]
13. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
14. Lentiginous melanoma in situ treatment with topical imiquimod: need for individualized regimens.
Missall TA; Hurley MY; Fosko SW
Arch Dermatol; 2010 Nov; 146(11):1309-10. PubMed ID: 21079078
[No Abstract] [Full Text] [Related]
15. [Histological findings during the treatment of skin neoplasias with 5-fluorouracil ointment].
Zala L
Dermatologica; 1972; 145(5):326-33. PubMed ID: 4654411
[No Abstract] [Full Text] [Related]
16. Topical vitamin-A-acid therapy for cutaneous metastatic melanoma.
Levine N; Meyskens FL
Lancet; 1980 Aug; 2(8188):224-6. PubMed ID: 6105393
[TBL] [Abstract][Full Text] [Related]
17. Evolution of melanocytic nevi under vemurafenib, followed by combination therapy with dabrafenib and trametinib for metastatic melanoma.
Giurcaneanu C; Nitipir C; Popa LG; Forsea AM; Popescu I; Bumbacea RS
Acta Dermatovenerol Croat; 2015; 23(2):114-21. PubMed ID: 26228819
[TBL] [Abstract][Full Text] [Related]
18. Pigmented epithelioid melanocytoma: a recently described melanocytic tumour of low malignant potential.
Lim C; Murali R; McCarthy SW; Krivanek J; Scolyer RA
Pathology; 2010 Apr; 42(3):284-6. PubMed ID: 20350224
[No Abstract] [Full Text] [Related]
19. MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium.
Sedghizadeh PP; Williams JD; Allen CM; Prasad ML
Med Sci Monit; 2005 Jul; 11(7):BR189-94. PubMed ID: 15990678
[TBL] [Abstract][Full Text] [Related]
20. Nodular superficial pigmented basal cell epitheliomas.
Shelley WB; Wood MG
Arch Dermatol; 1982 Nov; 118(11):928-30. PubMed ID: 7138053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
